ISQ Differences Between Different Implants in Post-extraction Sockets

March 24, 2025 updated by: Paolo Carosi, University of Rome Tor Vergata

Effect of Time and Local Factors on Hydrophilic Tissue Level Implants in Post-extraction Sites: a RCT

Two different implants will be used in post-extraction sockets and ISQ will be recorded monthly from insertion moment to 12 months of follow up to understand if ISQ can be affected by implant macro design

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • RM
      • Rome, RM, Italy, 00133

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients (at least 18 years old) presenting with failing tooth.
  • no recession of gingival contour of tooth to be extracted
  • no periodontal bone loss of neighboring teeth
  • no implants in neighboring teeth
  • class I extraction socket (intact buccal wall)
  • atraumatic extraction of the tooth with intact socket walls remaining.

Exclusion Criteria:

  • deep bite (severe II class)
  • systemic disease (diabetes, osteoporosis)
  • heavy smokers (more than 10 cigarettes/day)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: TISSUE LEVEL X
Implants with aggressive macro design
Screw a smart peg into the implant and record the values from a dedicated device
Experimental: TISSUE LEVEL C
Implants with less aggressive macro design
Screw a smart peg into the implant and record the values from a dedicated device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
IMPLANT STABILITY QUOTIENT
Time Frame: Monthly from T0 (implant insertion) to T12 (12 months after implant placement)
Values of risonance of implants taken by means of a dedicated device that translate the risonance of each implant into a number (0-99).
Monthly from T0 (implant insertion) to T12 (12 months after implant placement)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insertion torque
Time Frame: At implant placement
Mechanical resistance of the bone at implant placement
At implant placement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

February 28, 2027

Study Registration Dates

First Submitted

November 21, 2024

First Submitted That Met QC Criteria

November 26, 2024

First Posted (Actual)

December 2, 2024

Study Record Updates

Last Update Posted (Actual)

March 28, 2025

Last Update Submitted That Met QC Criteria

March 24, 2025

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • TLCVSTLX

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Implant Stability

Clinical Trials on Implant stability quotient

Subscribe